This summer there will be a particularly large amount of ticks and thus a higher risk of getting meningitis or Lyme disease (borreliosis), because these diseases are transmitted by ticks. Scientists
The first antibiotic against tuberculosis that has been developed in Germany is now ready for clinical testing. BTZ043, as the newly developed drug substance is called, is also effective against
The German Federal Ministry of Education and Research is joining forces with international partners in a new initiative to promote research into antimicrobial resistance (AMR). The aim is to fight
The advisory board has appointed Professor Christoph Lange, Chief Physician of the Medical Clinic of the Research Center Borstel Hospital as the new Medical Director. Christoph Lange is Co-coordinator
Christoph Lange was recently appointed as Medical Director of the Research Center Borstel. From here, he substantially contributes to clinical tuberculosis research in Europe, also monitoring the
Prof Rolf Müller was honoured with the Inhoffen Prize for his outstanding research in the field of microbial natural product discovery, particularly from Myxobacteria. Müller heads the Helmholtz
Early detection of antibiotic resistant pathogens can be life-saving. DZIF-scientists at the Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, have developed an
Human herpesvirus 6 infects most people all over the world. It is usually well controlled by the body, but it can cause diseases in immunocompromised individuals. As reported in ‘PLOS Pathogens’, DZIF
A new and rapid method for diagnosing pulmonary tuberculosis has been successfully developed at the Research Center Borstel. This innovative method constitutes an important building block for optimal
